Pharmaceutical Executive News

Comparative Effectiveness Research: Challenges for Pharma

Switching Rx drugs to OTC and adding comparative data could broaden access to treatment, writes Jill Wechsler.

DSM - Pharm Exec's 2012 Top 50 Pharma Companies

Polish Bid for Biotech Glory

Poland's government is aiming to make the Eastern European country a biotech powerhouse.

Country Report: South Africa

In just the past few years, South Africa has hit several key economic benchmarks demonstrating the country's upward trajectory.

Super-Size Me

Finding opportunities in the information explosion: big data, big challenges and big rewards.

Value-Based Pricing: Too High a Price for UK Pharma?

Changes to the P&R system in the UK could finally put some real metrics behind the elusive concept of value—but with payers clearly in the driver's seat, who needs clarity?

Best Practices: Commercial Analytics

If the relationship between marketers and commercial analytics is leveraged properly, it can help marketers make more informed strategic decisions for their brands.

Seeding Beyond the Base

The industry's reputation as a growth industry no one wants to pay for is more secure than ever.

Managing Information Overload

Companies know they need regulatory information management. What they don't always know is where to start and how to weave this vital capability across the enterprise.

Comparing Apples to Broccoli

In late March, the Supreme Court debated the merits—or lack thereof—of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?

Pharm Exec 50: Growth from the Bottom Up

More consolidation didn't boost sales at the top, but a handful of nimble newcomers posted impressive growth on the other end of the curve.

Government: Big Pharma's Best Friend in Emerging Markets?

To gain market access in emerging markets, pharma companies face pressure to offer a convincing Corporate Value Proposition to governments.

The Personal Touch in Digital Promotion

The shift from sales rep meetings to digital selling methods must include innovation and a physician-centered mindset in order to be successful.

Pharma's Winning Innovative Technology

Highlighting the companies awarded for exemplifying a high level of operational excellence with technology.

Establishing Case Quality Metrics

Defining and using quality metrics for adverse events case processing.

Emerging Markets: What's Your Corporate Value Proposition?

Pharma companies entering the emerging markets are under pressure to offer a convincing Corporate Value Proposition (CVP).

Sales Reps v. Pharma: The Overtime Issue

The Supreme Court's Decision on whether pharma sales reps should qualify for the 'outside sales exemption' could have far reaching implications, write Lisa A. Schreter and Kimberly J. Gost.

EU Responds to Troubled Medical Devices Sector

EU health ministers have stepped carefully around the medical devices sector, but the recent scandal concerning breast implants has the European Parliament baying for action.

Succeeding in Pharma as a Woman or Minority Professional

Broaden your industry exposure. Think beyond yourself... Timely advice from this year's HBA Woman of the Year, Carolyn Buck Luce.

IP: Time for a Reset?

IP must adapt to new ways of extracting value from assets the industry never knew it had, writes William Looney.